Business Description
Marvel Biosciences Corp
NAICS : 541714
SIC : 3741
ISIN : CA57384M1077
Description
Financial Strength
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.15 | |||||
Equity-to-Asset | -7.95 | |||||
Debt-to-Equity | -0.54 | |||||
Debt-to-EBITDA | -0.74 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -25.3 | |||||
3-Year EPS without NRI Growth Rate | -27.4 | |||||
3-Year FCF Growth Rate | -26 |
Momentum Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 86.62 | |||||
9-Day RSI | 70.5 | |||||
14-Day RSI | 62.91 | |||||
6-1 Month Momentum % | -14.29 | |||||
12-1 Month Momentum % | 71.43 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.22 | |||||
Quick Ratio | 0.22 | |||||
Cash Ratio | 0.14 | |||||
Days Payable | 478.33 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.9 | |||||
Shareholder Yield % | -6.63 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROA % | -310.78 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -3.63 | |||||
EV-to-EBITDA | -3.63 | |||||
EV-to-FCF | -5.7 | |||||
Earnings Yield (Greenblatt) % | -27.55 | |||||
FCF Yield % | -21.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Marvel Biosciences Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -0.06 | ||
Beta | 0.38 | ||
Volatility % | 72.9 | ||
14-Day RSI | 62.91 | ||
14-Day ATR (C$) | 0.006215 | ||
20-Day SMA (C$) | 0.12025 | ||
12-1 Month Momentum % | 71.43 | ||
52-Week Range (C$) | 0.055 - 0.19 | ||
Shares Outstanding (Mil) | 44.79 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Marvel Biosciences Corp Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Marvel Biosciences Corp Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Marvel Biosciences Corp Frequently Asked Questions
What is Marvel Biosciences Corp(TSXV:MRVL)'s stock price today?
When is next earnings date of Marvel Biosciences Corp(TSXV:MRVL)?
Does Marvel Biosciences Corp(TSXV:MRVL) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |